RetinalGenix Technologies (RTGN) Leases (2024 - 2026)

RetinalGenix Technologies recorded quarterly Leases of $3630.0 in Q1 2026, down 15.03% quarter-over-quarter from $4272.0 in Q4 2025, and down 41.39% year-over-year from $6194.0 in Q1 2025.

RetinalGenix Technologies' Leases history runs 3 years deep, the most recent figure standing at $3630.0 for Q1 2026.

  • In Q1 2026, Leases fell 41.39% year-over-year to $3630.0; the TTM figure through Mar 2026 stood at $3630.0 (down 41.39% YoY), while the FY2025 annual figure was $4272.0, down 37.5% from the prior year.
  • Leases came in at $3630.0 for Q1 2026 at RetinalGenix Technologies, down from $4272.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $7689.0 in Q3 2024 to a low of $3630.0 in Q1 2026.
  • A 3-year average of $5584.0 and a median of $5554.0 in 2025 frame the typical range for Leases.
  • Across the five-year window, Leases sank 36.09% in 2025 and tumbled 41.39% in 2026, its largest moves.
  • RetinalGenix Technologies' Leases stood at $6835.0 in 2024, then tumbled by 37.5% to $4272.0 in 2025, then retreated by 15.03% to $3630.0 in 2026.
  • According to Business Quant data, Leases over the past three periods registered $3630.0, $4272.0, and $4914.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 547.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 99.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 73.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 396.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 155.20 Mn
10 RetinalGenix Technologies - - - 3,630.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3,630.00
Dec 31, 2025 4,272.00
Sep 30, 2025 4,914.00
Jun 30, 2025 5,554.00
Mar 31, 2025 6,194.00
Dec 31, 2024 6,835.00
Sep 30, 2024 7,689.00